Evidence map›Paper›PMID 32749558›Full record

ArticleClinical research in cardiology : official journal of the German Cardiac Society2020

Temporal trends in the presentation of cardiovascular and cerebrovascular emergencies during the COVID-19 pandemic in Germany: an analysis of health insurance claims.

Moritz Seiffert, Fabian J Brunner, Marko Remmel, Götz Thomalla, Ursula Marschall, Helmut L'Hoest, Laura Acar, Eike S Debus, Stefan Blankenberg, Christian Gerloff and 1 more

Abstract read
In one paragraph

Article in Clinical research in cardiology : official journal of the German Cardiac Society, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 41 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
41citing papers in PubMed, 3 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

41 citing papers in PubMed, 3 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Article
  5. Myocarditis incidence and hospital mortality from 2007 to 2022: insights from a nationwide registry.Clinical research in cardiology : official journal of the German Cardiac Society · 2025
    Article
  6. Prognostic impact of disease-related complications in asymptomatic mitral regurgitation: a health insurance claims analysis.Clinical research in cardiology : official journal of the German Cardiac Society · 2025
    Article
  7. Article
  8. Article
  9. Article
  10. Myocarditis mortality with and without COVID-19: insights from a national registry.Clinical research in cardiology : official journal of the German Cardiac Society · 2024
    Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Effects of the COVID-19 pandemic on acute coronary syndromes in Germany during the first wave: the COVID-19 collateral damage study.Clinical research in cardiology : official journal of the German Cardiac Society · 2023
    Observational
  16. COVID-19 pandemic affects STEMI numbers and in-hospital mortality: results of a nationwide analysis in Germany.Clinical research in cardiology : official journal of the German Cardiac Society · 2023
    Article
  17. Observational
  18. Article
  19. Article
  20. Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Moritz Seiffert *Department of Cardiology, University Heart and Vascular Center UKE Hamburg, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Fabian J Brunner *Department of Cardiology, University Heart and Vascular Center UKE Hamburg, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Marko RemmelDepartment of Cardiology, University Heart and Vascular Center UKE Hamburg, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Götz ThomallaDepartment of Neurology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Ursula MarschallBARMER, Wuppertal, Germany.
Helmut L'HoestBARMER, Wuppertal, Germany.
Laura AcarBARMER, Wuppertal, Germany.
Eike S DebusResearch Group GermanVasc, Department of Vascular Medicine, University Heart and Vascular Center UKE Hamburg, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Stefan BlankenbergDepartment of Cardiology, University Heart and Vascular Center UKE Hamburg, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Christian GerloffDepartment of Neurology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Christian-Alexander BehrendtResearch Group GermanVasc, Department of Vascular Medicine, University Heart and Vascular Center UKE Hamburg, University Medical Center Hamburg-Eppendorf, Hamburg, Germany. behrendt@hamburg.de.ORCID http://orcid.org/0000-0003-0406-3319

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

aimsThe first reports of declining hospital admissions for major cardiovascular emergencies during the COVID-19 pandemic attracted public attention. However, systematic evidence on this subject is sparse. We aimed to investigate the rate of emergent hospital admissions, subsequent invasive treatments and comorbidities during the COVID-19 pandemic in Germany. METHODS AND

resultsThis was a retrospective analysis of health insurance claims data from the second largest insurance fund in Germany, BARMER. Patients hospitalized for acute myocardial infarction, acute limb ischemia, aortic rupture, stroke or transient ischemic attack (TIA) between January 1, 2019, and May 31, 2020, were included. Admission rates per 100,000 insured, invasive treatments and comorbidities were compared from January-May 2019 (pre-COVID) to January-May 2020 (COVID). A total of 115,720 hospitalizations were included in the current analysis (51.3% females, mean age 72.9 years). Monthly admission rates declined from 78.6/100,000 insured (pre-COVID) to 70.6/100,000 (COVID). The lowest admission rate was observed in April 2020 (61.6/100,000). Administration rates for ST-segment elevation myocardial infarction (7.3-6.6), non-ST-segment elevation myocardial infarction (16.8-14.6), acute limb ischemia (5.1-4.6), stroke (35.0-32.5) and TIA (13.7-11.9) decreased from pre-COVID to COVID. Baseline comorbidities and the percentage of these patients treated with interventional or open-surgical procedures remained similar over time across all entities. In-hospital mortality in hospitalizations for stroke increased from pre-COVID to COVID (8.5-9.8%).

conclusionsAdmission rates for cardiovascular and cerebrovascular emergencies declined during the pandemic in Germany, while patients' comorbidities and treatment allocations remained unchanged. Further investigation is warranted to identify underlying reasons and potential implications on patients' outcomes.

Indexed as

COVID-19Administrative Claims, HealthcareAgedCardiology Service, HospitalCardiovascular DiseasesCerebrovascular DisordersComorbidityDatabases, FactualEmergency Service, HospitalFemaleGermanyHealth Services AccessibilityHumansMalePatient Acceptance of Health CarePatient AdmissionCOVID-19EmergenciesHealth services researchMyocardial infarctionPandemicStroke

Identifiers

PMID32749558
PMCPMC7402080

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.